|

Cabo + Dostarlimab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Alabama at Birmingham1

Indications

  • Carcinoma1
  • Uterine Cancer1
  • Endometrial Cancer1
  • Gynecologic Cancer1
  • Cancer1

Birmingham, Alabama1 trial

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

O'Neal Comprehensive Cancer Center at UAB

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.